In a report released today, Alexander Nowak from Craig-Hallum assigned a Buy rating to Natera (NTRA – Research Report). The company’s shares opened today at $68.16.
Nowak covers the Healthcare sector, focusing on stocks such as CVRx, Guardant Health, and Exact Sciences. According to TipRanks, Nowak has an average return of -0.4% and a 39.94% success rate on recommended stocks.
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Natera with a $72.80 average price target, representing a 6.81% upside. In a report released on January 17, Piper Sandler also assigned a Buy rating to the stock with a $70.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
NTRA market cap is currently $8.01B and has a P/E ratio of -14.76.
Based on the recent corporate insider activity of 94 insiders, corporate insider sentiment is negative on the stock. This means that over the past quarter there has been an increase of insiders selling their shares of NTRA in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Natera (NTRA) Company Description:
Natera, Inc. engages in the discovery, development, and commercialization of genetic testing services. It offers Panorama Non-Invasive Prenatal Test, Horizon Carrier Screening, Spectrum Pre-implantation Genetic Screening and Spectrum Pre-implantation Genetic Diagnosis, Anora Products of Conception and Non-Invasive Paternity Testing. The company was founded by Matthew Rabinowitz and Jonathan Sheena in November 2003 and is headquartered in San Carlos, CA.
Read More on NTRA:
- Invitae Completes Sale of Reproductive Health Assets to Natera
- Natera announces jury verdict on damages below amount sought by Ravgen
- NeoGenomics price target lowered to $19 from $22 at TD Cowen
- NeoGenomics price target lowered to $21 from $25 at BTIG
- Natera price target raised to $85 from $75 at BTIG
